- Free from Publisher K Rossing, PK Christensen, BV Hansen, B … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 23 hypertensive patients with type 2
diabetes and nephropathy were enrolled in this double-blind randomized
cross-over trial with four treatment periods, each lasting 2 months. Each ... Cited by 52 - Related articles - BL Direct - All 5 versions
- ►oxfordjournals.org S Andersen, P Rossing, TR Juhl, J Deinum, … - Nephrology Dialysis Transplantation, 2002 - ERA-EDTA Results. Baseline values of albuminuria (geometric mean (95% CI)) and GFR
(means±SEM) were 1138 (904–1432) mg/24 h and 91±3 ml/min/1.73 m 2 ,
respectively. The blood pressure at baseline was 155/81±3/2 mmHg. All ... Cited by 56 - Related articles - BL Direct - All 4 versions
MS Weinberg, AJ Weinberg, R Cord, DH … - Journal of Renin-Angiotensin-Aldosterone System, 2001 - jraas.com The optimal doses of angiotensin-converting enzyme inhibitors (ACE-I) and/or
angiotensin II receptor blockers (ARBs) for maximal reduction in urinary protein
excretion are not known. Moreover, beneficial effects from ARBs, such as ... Cited by 35 - Related articles - All 4 versions
AJ Weinberg, DH Zappe, M Ashton, MS … - Am J Nephrol, 2004 - content.karger.com Background: The progression of renal disease is ameliorated by drugs that
inhibit the renin-angiotensin system (RAS). The doses used to slow the
progression of renal disease may not completely suppress the RAS for 24 h ... Cited by 38 - Related articles - BL Direct - All 6 versions
- Free from Publisher K Rossing, P Jacobsen, L Pietraszek, HH … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 20 patients (17 men and 3 women) with
type 2 diabetes along with hypertension and nephropathy were enrolled in this
double-blind, randomized, two-period, crossover trial of 8 weeks of ... Cited by 169 - Related articles - BL Direct - All 6 versions
- Free from Publisher K Rossing, PK Christensen, BR Jensen, HH … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We performed a randomized double-blind crossover
study of 2 months treatment with candesartan cilexetil 8 mg once daily and
placebo in addition to previous antihypertensive treatment. We included 18 ... Cited by 182 - Related articles - BL Direct - All 5 versions
FD Care - orthopedics.medscape.com Despite the proven benefit of RAS blockade by either ACEIs or ARBs, clinical
studies to date have found that such treatment slows but does not completely
arrest the progression of renal disease toward end-stage renal disease. ... Related articles - All 4 versions
- ►oxfordjournals.org S Andersen, P Jacobsen, L Tarnow, P Rossing … - Nephrology Dialysis Transplantation, 2003 - ERA-EDTA Results. Baseline levels of urinary albumin/creatinine ratio and 24 h mean
arterial blood pressure were 676 (402–1136) mg/g (geometric mean and 95% CI,
respectively) and 100±3 mmHg (mean±SEM). Albumin/creatinine ratio was ... Cited by 25 - Related articles - BL Direct - All 4 versions
J Luno, V Barrio, MA Goicoechea, C Gonzalez … - Kidney International, 2002 - nature.com To assess and compare the effects of lisinopril (up to 40 mg/day), candesartan
(up to 32 mg/day) and combination therapy (lisinopril up to 20 mg/day plus
candesartan up to 16 mg/day) on urinary protein excretion, 45 patients with ... Cited by 69 - Related articles - All 4 versions
S Andersen, K Blouch, J Bialek, M Deckert, … - Kidney international, 2000 - nature.com Differential solute clearances were performed in 12 individuals with early
diabetic nephropathy on two occasions: after 60 days of treatment with losartan
50 mg daily or a placebo. An uncharged preparation of nonreabsorbable ... Cited by 68 - Related articles - BL Direct - All 4 versions
